Automated objective outcome measures for clinical use in dysarthria
Automated objective outcome measures for clinical use in dysarthria
批准号:
10640837
负责人:
Sherman Charles
金额:
$71.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-07 至 2024-03-06
关键词:
AcousticsAdoptedAgeAmerican Speech-Language-Hearing AssociationAuditoryBenchmarkingBindingCharacteristicsClinicalClinical ResearchCommunicationCommunication impairmentCommunitiesComputer softwareDataData CollectionDevelopmentDysarthriaEvaluationFamiliarityFeedbackGenderHealthHealth Insurance Portability and Accountability ActHumanImpairmentIndividualInfrastructureInterventionInterviewJudgmentLanguageLearningLoudnessMeasuresMotorNeurologistOutcomeOutcome MeasureParticipantPathologistPatient CarePatient RecruitmentsPatientsPerformancePharmacologic SubstancePhasePopulationPopulation DistributionsPositioning AttributeProductionRegression AnalysisResearchResourcesSamplingSecondary toSmall Business Innovation Research GrantSpeechSpeech AcousticsSpeech DisordersSpeech IntelligibilitySpeech TherapySurveysSystemTechnologyTestingThinkingTimeTranslatingTreatment EfficacyTreatment outcomeUpdateWorkcareerclinical outcome measuresclinical practiceclinically relevantcommercializationcrowdsourcingexperienceimpressionimprovedinsightinterestmobile applicationnervous system disorderpatient populationprofessional atmosphereprospectiverecruitstatisticsusability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract / Summary
The inability to engage in spoken communication is among the most debilitating of all human conditions. In the
field of communication disorders, a speech-language pathologist’s (SLP’s) perceptual evaluation of the quality
of speech production is the gold standard for assessment and for documenting treatment progress. However,
decades of research have confirmed that auditory-perceptual judgments of speech are inherently biased,
which compromises reliability. The reason is that the human perceptual system is adaptive, with perceptual
bias accrued by working with an individual across multiple treatment sessions, or by working with patient
populations across a career. Thus, to reliably document treatment outcomes subjectively, it is necessary to
involve multiple, unfamiliar listeners. This is untenable in most clinical settings, which means that subjective
impressions are made by the treating clinicians. The reliance on subjective evaluation directly undermines the
quality of clinical practice and a clinician’s ability to demonstrate the efficacy of an intervention.
Aural Analytics has developed new objective acoustic speech metrics that reliably measure speech in
populations with neurological disorders. Its technology is based on a strong scientific premise and has been
adopted early by pharmaceutical companies and neurologists in clinical research. Aural Analytics has collected
and analyzed tens of thousands of speech samples using its technology, and the results are demonstrating
that its measures are robust, reliable, and more sensitive to longitudinal changes in speech than are other
existing outcome measures. We successfully completed a Phase I SBIR project with the aim of translating our
technology to SLP clinical practice. This Phase II proposal naturally builds on our previous work by connecting
the automated app-based outcome measures completed in Phase I to three complementary clinical
benchmarks. Specifically, SA1 will validate the Aural Analytics speech measures against the American
Speech-Language-Hearing Association’s (ASHA) Functional Communication Measures (FCM) for motor
speech; the Sentence Intelligibility Test; and expert ratings of speech characteristics. In addition, age and
gender-based norms for all objective measures will be obtained from collection of data from 600 new healthy
participants. In SA2, Aural Analytics will conduct a usability study with practicing speech-language pathologists
to assess real world utility and refine the user experience. The deliverable of this proposal will be a
fully-functional mobile application, validated by practicing SLPs in a clinical setting, with real time speech
outcome metrics validated with respect to existing community-accepted measures. This will result in objective
outcomes that fit into the workflow of the professional standard, thereby expediting our path to
commercialization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Automated objective outcome measures for clinical use in dysarthria
-
批准号:10323563
-
项目类别:
-
资助金额:$73.44万
-
财政年份:2019
-
负责人:Sherman Charles
-
依托单位:
海外基金